Calidi Biotherapeutics, Inc. Annual Operating Lease, Payments in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Calidi Biotherapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2023.
  • Calidi Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $349K, a 2.95% increase year-over-year.
  • Calidi Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.76M, a 101% increase from 2022.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.76M +$882K +101% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $877K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.